References are made to the announcement of Livzon Pharmaceutical Group Inc. dated 28 August 2019 and the circular of the Company dated 5 September 2019 regarding the proposed appointment of Mr. Tian Qiusheng ("Mr. Tian") and Mr. Wong Kam Wa as independent non-executive directors of the Company. At the 2019 third extraordinary general meeting (the "EGM") of the Company held on 15 October 2019, Mr. Tian and Mr. Wong were appointed as independent non-executive directors of the ninth session of the board of directors of the Company (the "Board"), whose term of appointment shall commence from the date of the EGM in which their appointment is approved and end on the expiry of the term of the ninth session of the Board. Mr. Tian Qiusheng has been an independent director of Zhuhai Port Co. Ltd. (000507.SZ) from December 2014 to present, an independent director of Guangzhou Lingnan Group Holdings Company Limited (000524.SZ) from August 2017 to present, and an independent non-executive director of Fineland Real Estate Services Group Limited (08376.HK) from October 2017 to present. Mr. Wong Kam Wa from May 2011 to March 2016, worked for Loeb & Loeb LLP. From April 2016 to July 2019, he worked for Anthony Siu & Co. Since July 2019, he has been a partner of TW Partners.